APA (7th ed.) Citation

Y, M., A, C., S, B., A, S., C, H., S, L., . . . T, F. (2023). Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales. Frontiers in medicine, 10, 1224922. https://doi.org/10.3389/fmed.2023.1224922

Chicago Style (17th ed.) Citation

Y, Merad, et al. "Case Report: Continuous Infusions of Ceftazidime-avibactam and Aztreonam in Combination Through Elastomeric Infusors for 12 Weeks for the Treatment of Bone and Joint Infections Due to Metallo-β-lactamase Producing Enterobacterales." Frontiers in Medicine 10 (2023): 1224922. https://doi.org/10.3389/fmed.2023.1224922.

MLA (9th ed.) Citation

Y, Merad, et al. "Case Report: Continuous Infusions of Ceftazidime-avibactam and Aztreonam in Combination Through Elastomeric Infusors for 12 Weeks for the Treatment of Bone and Joint Infections Due to Metallo-β-lactamase Producing Enterobacterales." Frontiers in Medicine, vol. 10, 2023, p. 1224922, https://doi.org/10.3389/fmed.2023.1224922.